Home /

Tablets

Dosage Form

Therapy Wise

Enquire Now

(Do not apply for jobs)

7
+
9
=
SR NO. GENERIC NAME COMPOSITION STRENGTH
1 Torsemide Tablets IP Each uncoated tablet contain: Torsemide Excipients Approved colour used 50 mg q.s.
2 Torsemide Tablets IP Each uncoated tablet contain: Torsemide Excipients Approved colour used 10 mg q.s.
3 Torsemide Tablets IP Each uncoated tablet contain: Torsemide Excipients Approved colour used 20 mg q.s.
4 Torsemide Tablets IP Each uncoated tablet contain: Torsemide Excipients Approved colour used 100 mg q.s.
5 Tadalafil Tablet IP Each film coated tablet contain: Tadalafil Excipients Approved colour used 20 mg q.s.
6 Metformin Hydrochloride (Prolong Release) and Glimepiride Tablets IP Each uncoated bilayerd tablet contains: Metformin Hydrochloride (Prolonged Release) Glimepiride Excipients Approved ColourUsed 500 mg 1mg q.s.
7 Metformin Hydrochloride (Prolong Release) and Glimepiride Tablest IP Each uncoated bilayerd tablet contains: Metformin Hydrochloride (Prolonged Release) Glimepiride Excipients Approved Colour Used 500 mg 2mg q.s.
8 Rosuvastatin Tablets IP Each film coated tablet contains: Rosuvastatin Calcium Equivalent to Rosuvastatin Excipients Approved Colour Used 5 mg q.s.
9 Rosuvastatin Tablets IP Each film coated tablet contains: Rosuvastatin Calcium Equivalent to Rosuvastatin Excipients Approved Colour Used 10 mg q.s.
10 Rosuvastatin Tablets IP Each film coated tablet contains: Rosuvastatin Calcium Equivalent to Rosuvastatin Excipients Approved Colour Used 20 mg q.s.
11 Glimepiride Tablets IP Each uncoated tablet contains: Glimepiride Excipients Approved Colour Used 1 mg q.s.
12 Glimepiride Tablets IP Each uncoated tablet contains: Glimepiride Excipients Approved Colour Used 2 mg q.s.
13 Metformin Hydrochloride Prolonged-Release Tablets IP Each uncoated Prolonged- Release Tablet Contains: Metformin Hydrochloride Excipients 100 mg q.s.
14 Metformin Hydrochloride Prolonged-Release Tablets IP Each uncoated Prolonged- Release Tablet Contains: Metformin Hydrochloride Excipients 500 mg q.s.
15 Metformin Hydrochloride Prolonged-Release Tablets IP Each uncoated Prolonged- Release Tablet Contains: Metformin Hydrochloride Excipients 850 mg q.s.
16 Metformin Hydrochloride Prolonged-Release Tablets IP Each uncoated Prolonged- Release Tablet Contains: Metformin Hydrochloride Excipients 1000 mg q.s.
17 Sitagliptin Phosphate Tablets IP Each film coated Tablet contains: Sitagliptin Phosphate Monohydrate Equ. to Sitagliptin Excipients Approved Colour used 25 mg q.s.
18 Sitagliptin Phosphate Tablets IP Each film coated Tablet contains: Sitagliptin Phosphate Monohydrate Equ. to Sitagliptin Excipients Approved Colour used 50 mg q.s.
19 Sitagliptin Phosphate Tablets IP Each film coated Tablet contains: Sitagliptin Phosphate Monohydrate Equ. to Sitagliptin Excipients Approved Colour used 100 mg q.s.
20 Voglibose Tablets IP Each uncoated tablet contains: Voglibose Excipients Approved Colour used 0.2 mg
21 Voglibose Dispersible Tablets IP Each uncoated dispersible tablet contains: Voglibose Excipients Approved Colour used 0.2 mg
22 Voglibose Dispersible Tablets IP Each uncoated dispersible tablet contains: Voglibose Excipients Approved Colour used 0.3 mg
23 Metformin Hydrochloride Prolonged-Release & Glimepiride Tablets IP Each Uncoated Bilayered Tablet Contains: Glimepiride Metformin Hydrochloride (As Prolonged Release) Excipients Approved colour used. 1mg 500mg q.s.
24 Metformin Hydrochloride Prolonged-Release & Glimepiride Tablets IP Each Uncoated Bilayered Tablet Contains: Glimepiride Metformin Hydrochloride (As Prolonged Release) Excipients Approved colour used. 2mg 500mg q.s.
25 Sildenafil Tablets IP Each film coated Tablet contains: Sildenafil Citrate Equ. to Sildenafil Excipients Approved Colour used 25 mg q.s.
26 Sildenafil Tablets IP Each film coated Tablet contains: Sildenafil Citrate Equ. To Sildenafil Excipients Approved Colour used 50 mg q.s.
27 Sildenafil Tablets IP Each film coated Tablet contains: Sildenafil Citrate Equ. To Sildenafil Excipients Approved Colour used 100 mg q.s.
28 Naproxen Tablets IP Each uncoated tablet contains: Naproxen Excipients Approved Colour used 250 mg q.s.
29 Naproxen Tablets IP Each uncoated tablet contains: Naproxen Excipients Approved Colour used 500 mg q.s.
30 Nifedipine Tablets IP Each uncoated tablet contains: Nifedipine Excipients Approved Colour used 5 mg q.s.
31 Nifedipine Tablets IP Each uncoated tablet contains: Nifedipine Excipients Approved Colour used 10 mg q.s.
32 Nifedipine Prolonged-release Tablets IP Each Prolonged- Release film coated Tablet Contains: Nifedipine Excipients Approved Colour used 10 mg q.s.
33 Nifedipine Prolonged-release Tablets IP Each Prolonged- Release film coated Tablet Contains: Nifedipine Excipients Approved Colour used 20 mg q.s
34 Atenolol Tablets IP Each uncoated tablet Contains: - Atenolol Excipients Approved colour used 50 mg q.s.
35 Atenolol Tablets IP Each uncoated tablet Contains: - Atenolol Excipients Approved colour used 100 mg q.s.
36 Glimepiride Tablets IP Each uncoated tablet contains: Glimepiride Excipients Approved Colour Used 3 mg q.s.
37 Glimepiride Tablets IP Each uncoated tablet contains: Glimepiride Excipients Approved Colour Used 4 mg q.s.
38 Telmisartan Tablets IP Each uncoated tablet contains: Temisartan Excipients Approved Colour Used 20 mg q.s.
39 Telmisartan Tablets IP Each uncoated tablet contains: Temisartan Excipients Approved Colour Used 40 mg q.s.
40 Telmisartan Tablets IP Each uncoated tablet contains: Temisartan Excipients Approved Colour Used 80 mg q.s.
41 Telmisartan and Amlodipine Tablets IP Each uncoated bilayered tablet contains: Telmisartan Amlodipine Besilate Equivalent to Amlodipine Excipients Approved Colour Used 40 mg 5 mg q.s.
42 Telmisartan and Amlodipine Tablets IP Each uncoated bilayered tablet contains: Telmisartan Amlodipine Besilate Equivalent to Amlodipine Excipients Approved Colour Used 80 mg 10 mg q.s.
43 Losartan Tablets IP Each film coated tablet contains: Losartan Potassium Excipients Approved Colour Used 50 mg q.s.
44 Losartan Tablets IP Each film coated tablet contains: Losartan Potassium Excipients Approved Colour Used 25 mg q.s.
45 Losartan Tablets IP Each film coated tablet contains: Losartan Potassium Excipients Approved Colour Used 100 mg q.s.
46 Telmisartan and Hydrochlorothiazide Tablets IP Each uncoated bilayered tablet contains: Telmisartan Hydrochlorothiazide Excipients Approved Colour Used 40 mg 12.5 mg q.s.
47 Telmisartan and Hydrochlorothiazide Tablets IP Each uncoated bilayered tablet contains: Telmisartan Hydrochlorothiazide Excipients Approved Colour Used 80 mg 12.5 mg q.s.
48 Amlodipine Tablets IP Each uncoated tablet contains: Amlodipine Besilate Equivalent to Amlodipine Excipients Approved Colour Used 5 mg q.s.
49 Amlodipine Tablets IP Each uncoated tablet contains: Amlodipine Besilate Equivalent to Amlodipine Excipients Approved Colour Used 10 mg q.s.
50 Azithromycin Tablets IP Each film coated tablet contains: Azithromycin (as dehydrate) Equivalent to Azithromycin Anhydrous Excipients Approved colour used 250 mg q.s.
51 Azithromycin Tablets IP Each film coated tablet contains: Azithromycin (as dehydrate) Equivalent to Azithromycin Anhydrous Excipients Approved colour used 500 mg q.s.
52 Atorvastatin Tablets IP Each film coated tablet contains: Atorvastatin Calcium Equivalent to Atorvastatin Excipients Approved colour used 10 mg q.s.
53 Atorvastatin Tablets IP Each film coated tablet contains: Atorvastatin Calcium Equivalent to Atorvastatin Excipients Approved colour used 20 mg q.s.
54 Atorvastatin Tablets IP Each film coated tablet contains: Atorvastatin Calcium Equivalent to Atorvastatin Excipients Approved colour used 40 mg q.s.
55 Atorvastatin Tablets IP Each film coated tablet contains: Atorvastatin Calcium Equivalent to Atorvastatin Excipients Approved colour used 80 mg q.s.
56 Atorvastatin Tablets IP Each film coated tablet contains: Atorvastatin Calcium Equivalent to Atorvastatin Excipients Approved colour used 5 mg q.s.
57 Methylprednisolone Tablets IP Each uncoated tablet contains: Methylprednisolone Excipients Approved Colour Used 2 mg q.s.
58 Methylprednisolone Tablets IP Each uncoated tablet contains: Methylprednisolone Excipients Approved Colour Used 4 mg q.s.
59 Methylprednisolone Tablets IP Each uncoated tablet contains: Methylprednisolone Excipients Approved Colour Used 16 mg q.s.
60 Methylprednisolone Tablets IP Each uncoated tablet contains: Methylprednisolone Excipients Approved Colour Used 8 mg q.s.
61 Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP Each uncoated tablet contains: Mefenamic Acid Dicyclomine Hydrochloride Excipients Approved Colour Used 250 mg 10 mg q.s.
62 Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP Each uncoated tablet contains: Mefenamic Acid Dicyclomine Hydrochloride Excipients Approved Colour Used 500 mg 20 mg q.s.
63 Levocetirizine Tablets IP Each film coated tablet contains: Levocetirizine Dihydrochloride Excipients Approved Colour Used 5 mg q.s.
64 Ketorolac Tromethamine Tablets IP Each uncoated tablet contains: Ketorolac Tromethamine Excipients Approved Colour Used 10 mg q.s.
65 Levodopa and Carbidopa Tablets IP Each uncoated Prolonged release tablet contains: Levodopa Carbidopa (Anhydrous) Excipients Approved Colour Used 100 mg 25 mg q.s.
66 Levodopa and Carbidopa Tablets IP Each uncoated Prolonged release tablet contains: Levodopa Carbidopa (Anhydrous) Excipients Approved Colour Used 200 mg 50 mg q.s.
67 Ramipril Tablets IP Each uncoated tablet contains: Ramipril Excipients Approved Colour used 1.25 mg q.s.
68 Ramipril Tablets IP Each uncoated tablet contains: Ramipril Excipients Approved Colour used 2.5 mg q.s.
69 Ramipril Tablets IP Each uncoated tablet contains: Ramipril Excipients Approved Colour used 5 mg q.s.
70 Ramipril Tablets IP Each uncoated tablet contains: Ramipril Excipients Approved Colour used 10 mg q.s.
71 Ramipril and HydrochlorothiazideTablets IP Each uncoated tablet contains: Ramipril Hydrochlorothiazide Excipients Approved Colour used 2.5 mg 12.5 mg q.s.
72 Ramipril and HydrochlorothiazideTablets IP Each uncoated tablet contains: Ramipril Hydrochlorothiazide Excipients Approved Colour used 5 mg 25 mg q.s.
73 Metoprolol Succinate Prolonged release Tablets IP Each film coated prolonged release tablets contains: Metoprolol Succinate Equivalent to Metoprolol Tartrate Excipients Approved colour used. 12.5 mg q.s.
74 Metoprolol Succinate Prolonged release Tablets IP Each film coated prolonged release tablets contains: Metoprolol Succinate Equivalent to Metoprolol Tartrate Excipients Approved colour used. 25 mg q.s.
75 Metoprolol Succinate Prolonged release Tablets IP Each film coated prolonged release tablets contains: Metoprolol Succinate Equivalent to Metoprolol Tartrate Excipients Approved colour used. 50 mg q.s.
76 Metoprolol Succinate Prolonged release Tablets IP Each film coated prolonged release tablets contains: Metoprolol Succinate Equivalent to Metoprolol Tartrate Excipients Approved colour used. 100 mg q.s.
77 Minoxidil Tablets IP Each uncoated tablet contains: Minoxidil Excipients Approved Colour used 2.5 mg q.s.
78 Minoxidil Tablets IP Each uncoated tablet contains: Minoxidil Excipients Approved Colour used 5 mg q.s.
79 Minoxidil Tablets IP Each uncoated tablet contains: Minoxidil Excipients Approved Colour used 10 mg q.s.
80 Ivermectin Tablets IP Each uncoated tablet contains: Ivermectin Excipients Approved Colour used 3 mg q.s.
81 Ivermectin Tablets IP Each uncoated tablet contains: Ivermectin Excipients Approved Colour used 6 mg q.s.
82 Ivermectin Tablets IP Each uncoated tablet contains: Ivermectin Excipients Approved Colour used 12 mg q.s.
83 Montelukast Sodium Tablets IP Each film coated tablet contains: Montelukast Sodium Equivalent to Montelukast Excipients Approved Colour used 5 mg q.s
84 Montelukast Sodium Tablets IP Each film coated tablet contains: Montelukast Sodium Equivalent to Montelukast Excipients Approved Colour used 10 mg q.s
85 Hydroxyzine Hydrochloride Tablets IP Each film coated tablet Contains: - Hydroxyzine Hydrochloride Excipients Approved colour used 10 mg q.s.
86 Hydroxyzine Hydrochloride Tablets IP Each film coated tablet Contains: - Hydroxyzine Hydrochloride Excipients Approved colour used 25 mg q.s.
87 Etodolac Tablets IP Each film coated tablet contains: Etodolac Excipients Approved Colour Used 200 mg q.s.
88 Etodolac Tablets IP Each film coated tablet contains: Etodolac Excipients Approved Colour Used 300 mg q.s.
89 Etodolac Tablets IP Each film coated tablet contains: Etodolac Excipients Approved Colour Used 400 mg q.s.
90 Cetirizine Hydrochloride Tablets IP Each film coated tablet contains: Cetirizine Hydrochloride Excipients Approved Colour Used 10 mg q.s.
91 Cetirizine Hydrochloride Tablets IP Each film coated tablet contains: Cetirizine Hydrochloride Excipients Approved Colour Used 20 mg q.s.
92 Clozapine Tablets IP Each film coated tablet contains: Clozapine Excipients Approved Colour Used 25 mg q.s.
93 Clozapine Tablets IP Each film coated tablet contains: Clozapine Excipients Approved Colour Used 50 mg q.s.
94 Clozapine Tablets IP Each film coated tablet contains: Clozapine Excipients Approved Colour Used 100 mg q.s.
95 Clozapine Tablets IP Each film coated tablet contains: Clozapine Excipients Approved Colour Used 200 mg q.s.
96 Mirtazapine Tablets IP Each film coated tablet contains: Mirtazapine Excipients Approved Colour Used 15 mg q.s.
97 Mirtazapine Tablets IP Each film coated tablet contains: Mirtazapine Excipients Approved Colour Used 30 mg q.s.
98 Mirtazapine Tablets IP Each film coated tablet contains: Mirtazapine Excipients Approved Colour Used 45 mg q.s.
99 Aripiprazole Tablets IP Each film coated tablet contains: Aripiprazole Excipients Approved Colour Used 5 mg q.s.
100 Aripiprazole Tablets IP Each film coated tablet contains: Aripiprazole Excipients Approved Colour Used 10 mg q.s.
101 Aripiprazole Tablets IP Each film coated tablet contains: Aripiprazole Excipients Approved Colour Used 15 mg q.s.
102 Aripiprazole Tablets IP Each film coated tablet contains: Aripiprazole Excipients Approved Colour Used 20 mg q.s.
103 Aripiprazole Tablets IP Each film coated tablet contains: Aripiprazole Excipients Approved Colour Used 30 mg q.s.
104 Amitriptyline Hydrochloride Tablets IP Each film coated tablet contains: Amitriptyline Hydrochloride Excipients Approved Colour Used 10 mg q.s.
105 Amitriptyline Hydrochloride Tablets IP Each film coated tablet contains: Amitriptyline Hydrochloride Excipients Approved Colour Used 25 mg q.s.
106 Amitriptyline Hydrochloride Tablets IP Each film coated tablet contains: Amitriptyline Hydrochloride Excipients Approved Colour Used 50 mg q.s.
107 Clarithromycin Tablets IP Each film coated tablet contains: Clarithromycin Excipients Approved colour used 250 mg q.s.
108 Clarithromycin Tablets IP Each film coated tablet contains: Clarithromycin Excipients Approved colour used 500 mg q.s.
109 Ebastine Tablets IP Each film coated tablet contains: Ebastine Excipients Approved colour used 5 mg q.s.
110 Ebastine Tablets IP Each film coated tablet contains: Ebastine Excipients Approved colour used 10 mg q.s.
111 Ebastine Tablets IP Each film coated tablet contains: Ebastine Excipients Approved colour used 20 mg q.s.
112 Donepezil Hydrochloride Tablets IP Each film coated tablet contains: Donepezil Hydrochloride Excipients Approved colour used 5 mg q.s.
113 Donepezil Hydrochloride Tablets IP Each film coated tablet contains: Donepezil Hydrochloride Excipients Approved colour used 10 mg q.s.
114 Amisulpride Tablets IP Each uncoated tablet contains: Amisulpride Excipients Approved colour used 50 mg q.s.
115 Amisulpride Tablets IP Each uncoated tablet contains: Amisulpride Excipients Approved colour used 100 mg q.s.
116 Amisulpride Tablets IP Each uncoated tablet contains: Amisulpride Excipients Approved colour used 200 mg q.s.
117 Amisulpride Tablets IP Each uncoated tablet contains: Amisulpride Excipients Approved colour used 300 mg q.s.
118 Amisulpride Tablets IP Each uncoated tablet contains: Amisulpride Excipients Approved colour used 400 mg q.s.
119 Risperidone Tablets IP Each film coated tablet contains: Risperidone Excipients Approved colour used 1 mg q.s.
120 Risperidone Tablets IP Each film coated tablet contains: Risperidone Excipients Approved colour used 2 mg q.s.
121 Risperidone Tablets IP Each film coated tablet contains: Risperidone Excipients Approved colour used 3 mg q.s.
122 Risperidone Tablets IP Each film coated tablet contains: Risperidone Excipients Approved colour used 4 mg q.s.
123 Lithium Carbonate Tablets IP Each uncoated tablet contains: Lithium Carbonate Excipients Approved Colour Used 300 mg q.s.
124 Olanzapine Tablets IP Each film coated tablet contains: Olanzapine Excipients Approved Colour Used 2.5 mg q.s.
125 Olanzapine Tablets IP Each film coated tablet contains: Olanzapine Excipients Approved Colour Used 5 mg q.s.
126 Olanzapine Tablets IP Each film coated tablet contains: Olanzapine Excipients Approved Colour Used 7.5 mg q.s.
127 Olanzapine Tablets IP Each film coated tablet contains: Olanzapine Excipients Approved Colour Used 10 mg q.s.
128 Olanzapine and Fluoxetine Tablets IP Each film coated tablet contains: Olanzapine Fluoxetine Hydrochloride Equivalent to Fluoxetine Excipients Approved Colour Used 5 mg 20 mg q.s.
129 Olanzapine and Fluoxetine Tablets IP Each film coated tablet contains: Olanzapine Fluoxetine Hydrochloride Equivalent to Fluoxetine Excipients Approved Colour Used 10 mg 20 mg q.s.
130 Ursodeoxycholic Acid Tablets IP Each film coated tablet contains: Ursodeoxycholic acid Excipients Approved Colour Used 150 mg q.s.
131 Ursodeoxycholic Acid Tablets IP Each film coated tablet contains: Ursodeoxycholic acid Excipients Approved Colour Used 300 mg q.s.
132 Ofloxacin and Ornidazole Tablets IP Each film coated tablet contains: Ofloxacin Ornidazole Excipients Approved Colour used 200 mg 500 mg q.s.
133 Venlafaxine Hydrochloride Tablets IP Each film coated tablet contains: Venlafaxine Hydrochloride Equivalent to Venlafaxine Excipients Approved Colour used 25 mg q.s.
134 Venlafaxine Hydrochloride Tablets IP Each film coated tablet contains: Venlafaxine Hydrochloride Equivalent to Venlafaxine Excipients Approved Colour used 37.5 mg q.s.
135 Venlafaxine Hydrochloride Tablets IP Each film coated tablet contains: Venlafaxine Hydrochloride Equivalent to Venlafaxine Excipients Approved Colour used 75 mg q.s.
136 Duloxetine Gastro-Resistant Tablets IP Each gastro-resistant tablet contains: Duloxetine Hydrochloride Eq. to Duloxetine Excipients Approved Colour used 20 mg q.s.
137 Duloxetine Gastro-Resistant Tablets IP Each gastro-resistant tablet contains: Duloxetine Hydrochloride Eq. to Duloxetine Excipients Approved Colour used 30 mg q.s.
138 Duloxetine Gastro-Resistant Tablets IP Each gastro-resistant tablet contains: Duloxetine Hydrochloride Eq. to Duloxetine Excipients Approved Colour used 40 mg q.s.
139 Duloxetine Gastro-Resistant Tablets IP Each gastro-resistant tablet contains: Duloxetine Hydrochloride Eq. to Duloxetine Excipients Approved Colour used 60 mg q.s.
140 Fluvoxamine Tablets IP Each film coated tablet contains: Fluvoxamine maleate Excipients Approved Colour used 25 mg q.s.
141 Fluvoxamine Tablets IP Each film coated tablet contains: Fluvoxamine maleate Excipients Approved Colour used 50 mg q.s.
142 Fluvoxamine Tablets IP Each film coated tablet contains: Fluvoxamine maleate Excipients Approved Colour used 100 mg q.s.
143 Quetiapine Tablets IP Each film coated tablet contains: Quetiapine Fumarate Eq. to Quetiapine Excipients Approved Colour used 25 mg q.s
144 Quetiapine Tablets IP Each film coated tablet contains: Quetiapine Fumarate Eq. to Quetiapine Excipients Approved Colour used 50 mg q.s
145 Quetiapine Tablets IP Each film coated tablet contains: Quetiapine Fumarate Eq. to Quetiapine Excipients Approved Colour used 100 mg q.s
146 Quetiapine Tablets IP Each film coated tablet contains: Quetiapine Fumarate Eq. to Quetiapine Excipients Approved Colour used 200 mg q.s
147 Imipramine Hydrochloride Tablets IP Each film coated tablet contains: Imipramine Hydrochloride Excipients Approved Colour used 10 mg q.s.
148 Imipramine Hydrochloride Tablets IP Each film coated tablet contains: Imipramine Hydrochloride Excipients Approved Colour used 25 mg q.s.
149 Escitalopram Tablets IP Each film coated tablet contains: Escitalopram Oxalate Eq. to Escitalopram Excipients Approved Colour used 5 mg q.s.
150 Escitalopram Tablets IP Each film coated tablet contains: Escitalopram Oxalate Eq. to Escitalopram Excipients Approved Colour used 10 mg q.s.
151 Escitalopram Tablets IP Each film coated tablet contains: Escitalopram Oxalate Eq. to Escitalopram Excipients Approved Colour used 20 mg q.s.
152 Paroxetine Tablets IP Each film coated tablet contains: Paroxetine Hydrochloride Hemihydrate Eq. to Paroxetine Excipients Approved Colour used 10 mg q.s.
153 Paroxetine Tablets IP Each film coated tablet contains: Paroxetine Hydrochloride Hemihydrate Eq. to Paroxetine Excipients Approved Colour used 20 mg q.s.
154 Paroxetine Tablets IP Each film coated tablet contains: Paroxetine Hydrochloride Hemihydrate Eq. to Paroxetine Excipients Approved Colour used 30 mg q.s.
155 Paroxetine Tablets IP Each film coated tablet contains: Paroxetine Hydrochloride Hemihydrate Eq. to Paroxetine Excipients Approved Colour used 40 mg q.s.
156 Sertraline Tablets IP Each film coated tablet contains: Sertraline Hydrochloride Eq. to Sertraline Excipients Approved Colour used 25 mg q.s.
157 Sertraline Tablets IP Each film coated tablet contains: Sertraline Hydrochloride Eq. to Sertraline Excipients Approved Colour used 50 mg q.s.
158 Sertraline Tablets IP Each film coated tablet contains: Sertraline Hydrochloride Eq. to Sertraline Excipients Approved Colour used 100 mg q.s.
159 Fluoxetine Tablets IP Each film coated tablet contains: Fluoxetine Hydrochloride Eq. to Fluoxetine Excipients Approved Colour used 10 mg q.s.
160 Fluoxetine Tablets IP Each film coated tablet contains: Fluoxetine Hydrochloride Eq. to Fluoxetine Excipients Approved Colour used 20 mg q.s.
161 Topiramate Tablets IP Each film coated tablet contains: Topiramate Excipients Approved Colour used 25 mg q.s.
162 Topiramate Tablets IP Each film coated tablet contains: Topiramate Excipients Approved Colour used 50 mg q.s.
163 Topiramate Tablets IP Each film coated tablet contains: Topiramate Excipients Approved Colour used 100 mg q.s.
164 Topiramate Tablets IP Each film coated tablet contains: Topiramate Excipients Approved Colour used 200 mg q.s.
165 Topiramate Tablets IP Each film coated tablet contains: Topiramate Excipients Approved Colour used 300 mg q.s.
166 Topiramate Tablets IP Each film coated tablet contains: Topiramate Excipients Approved Colour used 400 mg q.s.
167 Dosulepin Tablets IP Each film coated tablet contains: Dosulepin Hydrochloride Excipients Approved Colour used 25 mg q.s.
168 Dosulepin Tablets IP Each film coated tablet contains: Dosulepin Hydrochloride Excipients Approved Colour used 50 mg q.s.
169 Dosulepin Tablets IP Each film coated tablet contains: Dosulepin Hydrochloride Excipients Approved Colour used 75 mg q.s.
170 Pantoprazole Sodium & Domperidone Tablets Each enteric coated tablet contains: - Pantoprazole Sodium Eq. to Pantoprazole Domperidone Excipients Colour:-Approved colour used. 40 mg 10 mg q.s.
171 Nimesulide Tablets Each uncoated tablet contains: - Nimesulide Excipients Colour:-Approved colour used. 100 mg q.s.
172 Paracetamol Tablets IP Each uncoated tablet contains: - Paracetamol Excipients Colour:-Approved colour used. 650 mg q.s.
173 Deflazacort Tablets Each uncoated tablet contains: - Deflazacort Excipients Colour:-Approved colour used. 6 mg q.s.
174 Pantoprazole Gastro-Resistant Tablets IP Each enteric coated tablet contains: - Pantoprazole Sodium Eq. to Pantoprazole Excipients Colour: -Approved colour used. 40 mg q.s.
175 Ofloxacin Tablets IP Each film coated tablet contains: - Ofloxacin Excipients Colour: -Approved colour used. 200 mg q.s.
176 Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP Each film coated tablet contains: - Montelukast Sodium Eq. to Montelukast Levocetirizine Dihydrochloride Excipients Colour: -Approved colour used. 10 mg 5 mg q.s.
177 Aceclofenac & Paracetamol Tablets IP Each film coated tablet contains: - Aceclofenac Paracetamol Excipients Colour:-Approved colour used. 100 mg 325 mg q.s.
178 Febuxostat Tablets Each film coated tablet contains: - Febuxostat Excipients Colour: -Approved colour used. 40 mg q.s.
179 Paracetamol Tablets IP Each uncoated tablet contains: - Paracetamol Excipients Colour:-Approved colour used. 500 mg q.s.
180 Hydrochlorothiazide Tablets IP Each uncoated tablet contains: Hydrochlorothiazide Excipients Approved Colour used 25 mg q.s.
181 Hydrochlorothiazide Tablets IP Each uncoated tablet contains: Hydrochlorothiazide Excipients Approved Colour used 50 mg q.s.
182 Drotaverine HCL and Mefenamic acid Tablets Each film coated tablet contains: Drotaverine Hydrochloride Mefenamic Acid Excipients Approved Colour used 80 mg 250 mg q.s.
183 Digoxin Tablets IP Each uncoated tablet contains: Digoxin Excipients Approved Colour used 0.25 mg q.s.
184 Tadalafil Tablets IP Each film coated tablet contains: Tadalafil Excipients Approved Colour used 10 mg q.s.
185 Levetiracetam Oral Solution IP Each 5 ml Contains: Levetiracetam In a flavoured Syrupy base Approved Colour used 500 mg q.s.
186 Levetiracetam Prolonged-release Tablets IP Each film coated prolonged-release tablet contains: Levetiracetam Excipients Approved Colour used 500 mg q.s.
187 Levetiracetam Prolonged-release Tablets IP Each film coated prolonged-release tablet contains: Levetiracetam Excipients Approved Colour used 750 mg q.s.
188 Levetiracetam Prolonged-release Tablets IP Each film coated prolonged-release tablet contains: Levetiracetam Excipients Approved Colour used 1000 mg q.s.
189 Levetiracetam Tablets IP Each film coated tablet contains: Levetiracetam Excipients Approved Colour used 250 mg q.s.
190 Levetiracetam Tablets IP Each film coated tablet contains: Levetiracetam Excipients Approved Colour used 500 mg q.s.
191 Levetiracetam Tablets IP Each film coated tablet contains: Levetiracetam Excipients Approved Colour used 750 mg q.s.
192 Levetiracetam Tablets IP Each film coated tablet contains: Levetiracetam Excipients Approved Colour used 1000 mg q.s.
193 Ondansetron Orally Disintegrating Tablets IP Each uncoated orally disintegrating tablet contains: Ondansetron Hydrochloride equivalent to Ondansetron Excipients Approved Colour used 4 mg q.s.
194 Ondansetron Orally Disintegrating Tablets IP Each uncoated orally disintegrating tablet contains: Ondansetron Hydrochloride equivalent to Ondansetron Excipients Approved Colour used 8 mg q.s.
195 Esomeprazole Gastro-Resistant Tablets IP Each enteric coated tablet contains: Esomeprazole Magnesium Trihydrate Eq. to Esomeprazole Excipients Approved Colour used 20 mg q.s.
196 Esomeprazole Gastro-Resistant Tablets IP Each enteric coated tablet contains: Esomeprazole Magnesium Trihydrate Eq. to Esomeprazole Excipients Approved Colour used 30 mg q.s.
197 Esomeprazole Gastro-Resistant Tablets IP Each enteric coated tablet contains: Esomeprazole Magnesium Trihydrate Eq. to Esomeprazole Excipients Approved Colour used 40 mg q.s.
198 Rabeprazole Gastro-Resistant Tablets IP Each enteric coated tablet contains: Rabeprazole Sodium Excipients Approved Colour used 10 mg q.s.
199 Rabeprazole Gastro-Resistant Tablets IP Each enteric coated tablet contains: Rabeprazole Sodium Excipients Approved Colour used 20 mg q.s.
200 Sodium Valproate Tablets IP Each coated tablet contains: Sodium Valproate Excipients Approved Colour used 100 mg q.s.
201 Sodium Valproate Tablets IP Each coated tablet contains: Sodium Valproate Excipients Approved Colour used 200 mg q.s.
202 Sodium Valproate Gastro- Resistant Tablets IP Each enteric coated tablet contains: Sodium Valproate Excipients Approved Colour used 100 mg q.s.
203 Sodium Valproate Gastro- Resistant Tablets IP Each enteric coated tablet contains: Sodium Valproate Excipients Approved Colour used 200 mg q.s.
204 Simvastatin Tablets IP Each film coated tablet contains: Simvastatin Excipients Approved Colour used 20 mg q.s.
205 Folic Acid Tablets IP Each uncoated tablet contains: Folic Acid Excipients Appropriate overages of vitamins added to compensate loss on storage. Approved Colour used 5 mg q.s.
206 Glibenclamide Tablets IP Each uncoated tablet contains: Glibenclamide Excipients Approved Colour used 5 mg q.s.
207 Carbamazepine Tablets IP Each uncoated tablet contains: Carbamazepine Excipients Approved Colour used 200 mg q.s.
208 Prednisolone Tablets IP Each uncoated tablet contains: Prednisolone Excipients Approved Colour used 5 mg q.s.
209 Propranolol Tablets IP Each uncoated tablet contains: Propranolol Hydrochloride Excipients Approved Colour used 10 mg q.s.
210 Divalproex Gastro-Resistant Tablets IP Each enteric coated tablet contains: Divalproex Sodium Eq. to Valproic Acid Excipients Approved Colour used 125 mg q.s.
211 Divalproex Gastro-Resistant Tablets IP Each enteric coated tablet contains: Divalproex Sodium Eq. to Valproic Acid Excipients Approved Colour used 250 mg q.s.
212 Divalproex Gastro-Resistant Tablets IP Each enteric coated tablet contains: Divalproex Sodium Eq. to Valproic Acid Excipients Approved Colour used 500 mg q.s.
213 Divalproex Prolonged- Release Tablets IP Each film coated prolonged-release tablet contains: Divalproex Sodium Eq. to Valproic Acid Excipients Approved Colour used 125 mg q.s.
214 Divalproex Prolonged- Release Tablets IP Each film coated prolonged-release tablet contains: Divalproex Sodium Eq. to Valproic Acid Excipients Approved Colour used 250 mg q.s.
215 Divalproex Prolonged- Release Tablets IP Each film coated prolonged-release tablet contains: Divalproex Sodium Eq. to Valproic Acid Excipients Approved Colour used 500 mg q.s.
216 Divalproex Prolonged- Release Tablets IP Each film coated prolonged-release tablet contains: Divalproex Sodium Eq. to Valproic Acid Excipients Approved Colour used 750 mg q.s.
217 Divalproex Prolonged- Release Tablets IP Each film coated prolonged-release tablet contains: Divalproex Sodium Eq. to Valproic Acid Excipients Approved Colour used 1000 mg q.s.
218 Phenytoin Tablets IP Each film coated tablet contains: Phenytoin Sodium Excipients Approved Colour used 50 mg q.s.
219 Phenytoin Tablets IP Each film coated tablet contains: Phenytoin Sodium Excipients Approved Colour used 100 mg q.s.
220 Tinidazole Tablets IP Each film coated tablet contains: Tinidazole Excipients Approved Colour used 150 mg q.s.
221 Tinidazole Tablets IP Each film coated tablet contains: Tinidazole Excipients Approved Colour used 300 mg q.s.
222 Tinidazole Tablets IP Each film coated tablet contains: Tinidazole Excipients Approved Colour used: 500 mg q.s.
223 Spironolactone Tablets IP Each uncoated tablet contains: Spironolactone Excipients Approved Colour used 25 mg q.s.
224 Spironolactone Tablets IP Each uncoated tablet contains: Spironolactone Excipients Approved Colour used 50 mg q.s.
225 Spironolactone Tablets IP Each uncoated tablet contains: Spironolactone Excipients Approved Colour used 100 mg q.s.
226 Alfuzosin Prolonged- Release Tablets IP Each film coated prolonged-release tablet contains: Alfuzosin Hydrochloride Excipients Approved Colour used 10 mg q.s.
227 Cilostazol Tablets IP Each uncoated tablet contains: Cilostazol Excipients Approved Colour used 50 mg q.s.
228 Cilostazol Tablets IP Each uncoated tablet contains: Cilostazol Excipients Approved Colour used 100 mg q.s.
229 Cilostazol Tablets IP Each uncoated tablet contains: Cilostazol Excipients Approved Colour used 200 mg q.s.
230 Leflunomide Tablets IP Each film coated tablet contains: Leflunomide Excipients Approved Colour used 10 mg q.s.
231 Leflunomide Tablets IP Each film coated tablet contains: Leflunomide Excipients Approved Colour used 20 mg q.s.
232 Leflunomide Tablets IP Each film coated tablet contains: Leflunomide Excipients Approved Colour used 100 mg q.s.
233 Drotaverine Hydrochloride Tablets IP Each film coated tablet contains: Drotaverine Hydrochloride Excipients Approved Colour used 40mg q.s.
234 Drotaverine Hydrochloride Tablets IP Each film coated tablet contains: Drotaverine Hydrochloride Excipients Approved Colour used 80mg q.s.
235 Diclofenac Sodium and Paracetamol Tablets IP Each uncoated tablet contains: Diclofenac Sodium Paracetamol Excipients Approved Colour used 50 325 q.s.
236 Etoricoxib Tablets IP Each film coated tablet contains: Etoricoxib Excipients Approved Colour used 60 mg q.s.
237 Etoricoxib Tablets IP Each film coated tablet contains: Etoricoxib Excipients Approved Colour used 90 mg q.s.
238 Etoricoxib Tablets IP chlorpheniramine Maleate Etoricoxib Excipients Approved Colour used 120 mg q.s.
239 Frusemide Tablets IP Each uncoated tablet contains: Frusemide Excipients Approved Colour used 40 mg q.s.
240 Chlorpheniramine Maleate Tablets IP Each uncoated tablet contains: Chlorpheniramine Maleate Excipients Approved Colour used 4 mg q.s.
241 Etodolac and Thiocolchicoside Tablets Each film coated tablet contains: Etodolac Thiocolchicoside Excipients Approved Colour used 400 mg 4 mg q.s.
242 Naproxen & Domperidone Tablets Each film coated tablet contains: Naproxen Domperidone Excipients Approved Colour used 500 mg 10 mg q.s.
243 Naproxen & Domperidone Tablets Each film coated tablet contains: Naproxen Domperidone Excipients Approved Colour used 250 mg 10 mg q.s.
244 Ranitidine and Domperidone Tablets Each film coated tablet contains: Ranitidine Domperidone Excipients Approved Colour used 150 mg 10 mg q.s.
245 Nimesulide and Paracetamol Tablets Each uncoated tablet contains: Nimesulide Paracetamol Excipients Approved Colour used 100 mg 325 mg q.s.
246 Bisoprolol Fumarate Tablets USP Each film coated tablet contains: Bisoprolol Fumarate Excipients Approved Colour used 2.5 mg q.s.
247 Bisoprolol Fumarate Tablets USP Each film coated tablet contains: Bisoprolol Fumarate Excipients Approved Colour used 5 mg q.s.
248 Bisoprolol Fumarate Tablets USP Each film coated tablet contains: Bisoprolol Fumarate Excipients Approved Colour used 10 mg q.s.
249 Lisinopril Tablets IP Each uncoated tablet contains: Lisinopril Eq. to anhydrous Lisinopril Excipients Approved Colour used 5 mg q.s.
250 Lisinopril Tablets IP Each uncoated tablet contains: Lisinopril Eq. to anhydrous Lisinopril Excipients Approved Colour used 10 mg q.s.
251 Linezolid Tablets IP Each film coated tablet contains: Linezolid Excipients Approved Colour used 600 mg q.s.
252 Etoricoxib and Thiocolchicoside Tablets Each film coated tablet contains: Etoricoxib Thiocolchicoside Excipients Approved Colour used 60 mg 4 mg q.s.
253 Etoricoxib and Thiocolchicoside Tablets Each film coated tablet contains: Etoricoxib Thiocolchicoside Excipients Approved Colour used 60 mg 8 mg q.s.
254 Dexamethasone Tablets IP Each uncoated tablet contains: Dexamethasone Excipients Approved Colour used 0.5 mg q.s.
255 Aceclofenac Sustained- release Tablets Each film coated sustained- release tablet contains: Aceclofenac Excipients Approved Colour used 200 mg q.s.
256 Aceclofenac, Paracetamol & Chlorzoxazone Tablets Each film coated tablet contains: Aceclofenac Paracetamol Chlorzoxazone Excipients Approved Colour used 100 mg 325 mg 250 mg q.s.
257 Aceclofenac, Paracetamol & Serratiopeptidase Tablets Each film coated tablet contains: Aceclofenac Paracetamol Serratiopeptidase (as enteric coated granules eq. to 20,000 IU Enzyme activity units of Serratiopeptidase) Excipients Approved Colour used 100 mg 325 mg 10 mg q.s.
258 Ciprofloxacin Tablets IP Each film coated tablet contains: Ciprofloxacin Hydrochloride Excipients Approved Colour used 250 mg q.s.
259 Ciprofloxacin Tablets IP Each film coated tablet contains: Ciprofloxacin Hydrochloride Excipients Approved Colour used 500 mg q.s.
260 Levocetirizine and Ambroxol Tablets Each film coated tablet contains: Levocetirizine Hydrochloride Ambroxol Hydrochloride Excipients Approved Colour used 5 mg 60 mg q.s.
261 Serratiopeptidase Tablets IP Each enteric coated tablet contains: Serratiopeptidase (20,000 Serratiopeptidase units) Excipients Approved Colour used 10 mg q.s.
262 Diclofenac Potassium & Serratiopeptidase Tablets Each enteric film coated tablet contains: Diclofenac Potassium Serratiopeptidase (20,000 units) Excipients Approved Colour used 50 mg 10 mg q.s.
263 Pregabalin & Nortriptyline HCL Tablets Each film coated tablets contains: Pregabalin Nortriptyline Hydrochloride Eq. to Nortriptyline Excipients Approved Colours used 75 mg 10 mg q.s.
264 Terbinafine Tablets IP Each uncoated tablets contains: Terbinafine Hydrochloride Eq. to Terbinafine Excipients Approved Colours used 250 mg q.s.
265 Terbinafine Tablets IP Each uncoated tablets contains: Terbinafine Hydrochloride Eq. to Terbinafine Excipients Approved Colours used 500 mg q.s.
266 Citicoline Tablets IP Each film coated tablets contains: Citicoline Sodium Eq. to Citicoline Excipients Approved Colours used 500 mg q.s.
267 Citicoline & Piracetam Tablets Each film coated tablets contains: Citicoline Sodium Eq. to Citicoline Piracetam Excipients Approved Colours used 500 mg 400 mg q.s.
268 Citicoline & Piracetam Tablets Each film coated tablets contains: Citicoline Sodium Eq. to Citicoline Piracetam Excipients Approved Colours used 500 mg 800 mg q.s.
269 Metformin Hydrochloride (ER), Pioglitazone and Glimepiride Tabl Each uncoated Bilayered tablet contains: Metformin Hydrochloride (as Extended release) Pioglitazone Hydrochloride Eq. to Pioglitazone Glimepiride Excipients Approved Colour used 500 mg 15 mg 1 mg q.s
270 Metformin Hydrochloride (ER), Pioglitazone and Glimepiride Tablets Each uncoated Bilayered tablet contains: Metformin Hydrochloride (as Extended release) Pioglitazone Hydrochloride Eq. to Pioglitazone Glimepiride Excipients Approved Colour used 500 mg 15 mg 2 mg q.s
271 Glimepiride and Metformin Hydrochloride (Sustained Release) Tablets IP Each uncoated Bilayered tablet contains: Glimepiride Metformin Hydrochloride (as Sustained release) Excipients Approved Colour used 1 mg 1000 mg q.s. q.s.
272 Methylcobalamin Extended Release Tablets Each extended release tablet Contains: - Methylcobalamin Excipients Approved colour used 1500 mcg q.s.
273 Mefenamic Acid Tablets BP Each uncoated tablet Contains: -Mefenamic Acid Excipients Approved colour used 500 mg q.s.
274 Mefenamic Acid and Paracetamol Tablets Each uncoated tablet contains: Mefenamic Acid Paracetamol Excipients Approved Colour Used 500 mg 325 mg q.s.
275 Rabeprazole Sodium & Domperidone Tablets Each Enteric coated tablet contains: Rabeprazole sodium Domperidone Excipients Approved Colour Used 20 mg 10 mg q.s.
276 Labetalol Hydrochloride Tablets IP Each uncoated tablet contains: Labetalol Hydrochloride Excipients Approved colour used 100 mg q.s.
277 Doxylamine Succinate, Pyridoxine HCl & Folic acid Tablets Each enteric coated tablet contains;- Doxylamine Succinate Pyridoxine Hydrochloride Folic acid Excipients Approved colour used 20 mg 20 mg 5 mg q.s.
278 Tolperisone Hydrochloride Tablets Each film coated tablet contains: Tolperison Hydrochloride Excipients Approved colour used 150 mg q.s.
279 Flavoxate Tablets IP Each film coated tablet contains: Flavoxate Hydrochloride Excipients Approved colour used 200 mg q.s.
280 Atorvastatin & Fenofibrate Tablets IP Each film coated tablet contains: Atorvastatin Calcium Eq. to Atorvastatin Fenofibrate (micronized) Excipients Approved colour used 10 mg 160 mg q.s.
281 Aceclofenac & Thiocolchicoside Tablets Each film coated tablet contains: Aceclofenac Thiocolchicoside Excipients Approved Colour used 100 mg 4 mg q.s.
282 Aceclofenac & Thiocolchicoside Tablets Each film coated tablet contains: Aceclofenac Thiocolchicoside Excipients Approved Colour used 100 mg 8 mg q.s.
283 Fexofenadine Hydrochloride Tablets IP Each film coated tablet contains: Fexofenadine Hydrochloride Excipients Approved Colour used 180 mg q.s.
284 Carvedilol Tablets IP Each uncoated tablet contains: Carvedilol Excipients Approved Colour used 3.125 mg q.s.
285 Carvedilol Tablets IP Each uncoated tablet contains: Carvedilol Excipients Approved Colour used 6.25 mg q.s.
286 Metoprolol Succinate Extended-Release, Cilnidipine & Telmisartan Tablets Each film coated bilayer tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended-Release) Cilnidipine Telmisartan Excipients Approved Colour used 23.75 mg 25 mg 10 mg 40 mg q.s.
287 Etodolac Extended Release Tablets IP Each film coated extended release tablet contains: Etodolac Excipients Approved Colour used 600 mg q.s
288 Ferrous Ascorbate, Folic Acid and Zinc Sulphate Tablets Each film coated tablet contains: Ferrous Ascorbate Eq. to elemental Iron Folic Acid Zinc Sulphate Monohydrate Eq. to elemental Zinc Excipients Approved Colour used 100 mg 1500 mcg 22.5 mg q.s.
289 Calcium Citrate, Magnesium, Zinc With Vitamin D3 Tablets Each uncoated tablet contains: Calcium Citrate Magnesium Hydroxide Zinc Sulphate Monohydrate Eq. to elemental Zinc Vitamin D3 Excipients Approved Colour used 1000 mg 100 mg 4 mg 200 IU q.s.
290 Isoxsuprine Hydrochloride Tablets (Sustained Release) Each uncoated Sustained Release tablet contains: Isoxsuprine Hydrochloride Excipients Approved Colour used 40 mg q.s.
291 Isoxsuprine Tablets IP Each uncoated tablet contains: Isoxsuprine Hydrochloride Excipients Approved Colour used 20 mg q.s.
292 Vitamin C Chewable Tablets With Zinc Each chewable tablet contains: Ascorbic acid Sodium Ascorbic Eq. to Ascorbic Acid Zinc Citrate Eq. to elemental Zinc Excipients Approved Colour used 100 mg 450 mg 400 mg 5 mg q.s.
293 Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine Hydrochloride Tablets Each film coated tablet contains: Paracetamol Phenylephrine Hydrochloride Caffeine (Anhydrous) Diphenhydramine Hydrochloride Excipients Approved Colour used 500 mg 5 mg 30 mg 25 mg q.s.
294 Amitriptyline Hydrochloride Tablets IP Each film coated tablet contains: Amitriptyline Hydrochloride Excipients Approved Colour used 25 mg q.s
295 Tadalafil Tablets IP Each film coated tablet contains: Tadalafil Excipients Approved Colour used 2.5 mg
296 Tadalafil Tablets IP Each film coated tablet contains: Tadalafil Excipients Approved Colour used 5 mg
297 Levofloxacin Tablets IP Each film coated tablet contains: Levofloxacin Hemihydrate Eq. to Levofloxacin Excipients Approved Colour used 500 mg q.s.
298 Gliclazide & Metformin Hydrochloride Tablets Each uncoated tablet contains: Gliclazide Metformin Hydrochloride Excipients Approved Colour used 80 mg 500 mg q.s.
299 Nitrofurantoin Sustained Release Tablets Each film-coated sustained release tablet contains: Nitrofurantoin Excipients Approved Colour used 100 mg q.s.
300 Rifaximin Tablets Each film coated tablet contains: Rifaximin Excipients Approved Colour used 550 mg q.s.
301 Gliclazide Modified – Release & Metformin Hydrochloride Extended-Release Tablets Each uncoated bilayered tablet contains: Gliclazide (in modified-release form) Metformin Hydrochloride (in extended-release form) Excipients Approved Colour used 30 mg 500mg q.s.
302 Gliclazide Modified – Release & Metformin Hydrochloride Extended-Release Tablets Each uncoated bilayered tablet contains: Gliclazide (in modified-release form) Metformin Hydrochloride (in extended-release form) Excipients Approved Colour used 60 mg 500mg q.s.
303 Disulfiram Tablets IP Each uncoated tablet contains: Disulfiram Excipients Approved Colour used 500 mg q.s.
304 Roxithromycin Tablets IP Each film coated tablet contains: Roxithromycin Excipients Approved Colour used 150 mg q.s.
305 Ornidazole Tablets IP Each film-coated tablet contains: Ornidazole Excipients Approved Colour used 500 mg q.s.
306 Diacerein, Glucosamine Sulfate Potassium Chloride & Methylsulfonylmethane Tablets Each film coated tablet contains: Diacerein Glucosamine Sulfate Potassium Chloride Methylsulfonylmethane Excipients Approved Colour used 50mg 750mg 250mg q.s.

Best Tablet Manufacturing Company | Top Tablets Manufacturers

Tablet Manufacturing Company services play an essential part in the field of the pharmaceutical industry by ensuring that the highest standard of medicines is produced. With continued demand in the healthcare sector, there have been increased partnerships in pharmaceuticals that offer outstanding services and quality products that meet all safety and effectiveness criteria required. At Abhilashi Healthcare, we have managed to establish ourselves as one of the renowned manufacturers in the field of pharmaceuticals by offering various services that can meet different demands of our clients in this field. We have state-of-the-art facilities and professionals who comply with the existing guidelines within this field, and thus we ensure the manufacture of high-quality pharmaceutical tablets.

 

Best Tablet Manufacturing Company – Trusted Solutions for Quality Pharma Products

 

The pharmaceutical industry has immense trust in the manufacturers of medicines, which should be of high quality to compete at the international level. Therefore, the selection of a reliable tablet manufacturing company is important for companies seeking to make their presence felt in the healthcare industry. The role of a good manufacturer is not only limited to quality but includes regulation and efficiency as well.

 

Abhilashi Healthcare is known for its latest manufacturing equipment and quality control process in the production of various types of pharmaceutical tablets. State of the art technology is applied in our manufacturing facilities to provide the necessary quality control during each stage of the production process, ranging from formulation to packaging of our final products.

 

We are one of the leading tablet manufacturers that specialize in quality, innovation, and customer satisfaction. Our wide array of products comprises tablets for various therapeutic applications.

 

Pharmaceutical Tablets Manufacturers Offering Comprehensive Manufacturing Services

 

Reliable Pharma Tablets Manufacturers do not limit their services to merely providing manufacturing plants. Their services include developing formulations, product customization, packaging, labelling and preparing necessary documents for compliance.

 

The services provided by Abhilashi Healthcare include manufacturing of:

 

• Antibiotic Tablets

• Multivitamin Tablets

• Nutraceutical Tablets

• Anti-Inflammatory Tablets

• Antidiabetic Tablets

• Gastrointestinal Tablets

• Cardiac Care Tablets

• Herbal & Ayurvedic Tablets

 

We have earned a reputation as reliable Pharma Tablets Manufacturers because of our commitment to maintaining high quality in our tablets. As such, we are known to serve various pharmaceutical companies across the country.

 

We strictly comply with Good Manufacturing Practices (GMP) in all the manufacturing processes. In addition to that, we maintain quality during production.

 

Pharma Tablet Manufacturing with Advanced Technology and Quality Assurance

 

In today's Pharmaceuticals Tablets Manufacturing process requires knowledge and technology are required to have efficient production systems. Pharmaceutical companies require manufacturers that can make reliable tablets.

The processes involved in production at Abhilashi Healthcare include:

 

·       Source Materials Collection from Approved Suppliers

·       Development and Validation of Formulations

·       Granulation & Blending

·       Compression into Tablets

·       Coating & Finishing

·       Testing & Inspection of Quality

·       Packaging & Distribution

 

The equipment used in producing the products in our production plants is the latest in technology, ensuring maintenance of quality and efficiency in production. Our production processes are supervised by professional quality assurance personnel for compliance with standards.

 

As one of the trusted Pharma Tablets Manufacturers, we understand the need for uniformity in dosages and performance in production. That is why we take strict measures to guarantee product quality.

 

Tablet Contract Manufacturer for Flexible and Cost-Effective Production

 

Most of the pharmaceutical companies like to outsource their manufacturing requirements to a competent Tablet Contract Manufacturer. Outsourcing helps the companies concentrate more on marketing and distributing their products by allowing others to handle their manufacturing process.

 

Abhilashi Healthcare offers complete contract manufacturing services that can assist new business ventures and pharmaceutical companies, as well as other healthcare distributors and established names. Some of our services are:

 

·       Product Development Support

·       Formulation Customization

·       Private Label Manufacturing Services

·       Bulk Manufacturing

·       Packaging Services

·       Delivery and Regulatory Assistance

 

We serve as competent Tablet Contract Manufacturer who assists businesses to save costs and keep quality intact. Our flexible manufacturing abilities allow businesses to introduce products to the market faster.

 

Why Choose Abhilashi Healthcare as Your Contract Tablet Manufacturers Partner?

 

Selection of the manufacturing company is an important aspect when deciding on the quality of the product as well as expansion of business. Being professional Contract Tablet Manufacturers, we always try to provide you with value based solution and growth in the future.

 

Advantages of working with Abhilashi Healthcare:

 

Modern Manufacturing Infrastructure

 

Our company has modern infrastructure which helps us produce products in high volume with utmost efficiency.

 

Professional Experts in the Field

 

Pharmacists, quality analysts, and technicians are always ready to collaborate and manufacture products of excellent quality.

 

Regulatory Requirements Compliance

 

We adhere to all industry rules in manufacturing products according to the regulations.

 

Rich Product Portfolio

 

We manufacture tablets of various pharmaceutical groups, from vitamins to medicinal pills.

 

Cost Effective Services

 

With us, you will get a product of premium quality at an affordable price.

 

Prompt Order Execution

 

We have achieved this through appropriate ordering and distribution processes, ensuring delivery of your order on time.

 

As professional Contract Tablet Manufacturers, we constantly seek to establish and maintain lasting business relationships with our associates.



FAQs


Q1. What services does a Tablet Manufacturing Company offer?

 

The services provided by a Tablet Manufacturing Company include formulation development, tablet manufacturing, testing, packaging, labelling, and regulatory services. This assists pharmaceutical companies in promoting their products.

 

Q2. Why would you opt for a Tablet Contract Manufacturer?

 

Opting for a Tablet Contract Manufacturer is useful because it will enable businesses to cut down on infrastructural investments, save money, and deal with problems arising out of manufacturing. Business owners would have enough time to brand and sell their tablets.

 

Q3. How do Pharmaceutical Tablets Manufacturers keep up product quality?

 

Quality control measures and following GMP principles ensure high-quality products. In addition to this, Pharmaceutical Tablets Manufacturers use testing methods throughout the entire process of making the product.



Finding the right Tablet Manufacturing Company will be an important step for the success and growth of any pharmaceutical company that requires quality products. Being equipped with highly sophisticated manufacturing facilities, strong quality assurance processes, and customer-oriented services, Abhilashi Healthcare is one of those companies that can be considered reliable as a Tablets Manufacturer. With our professional Pharmaceutical Tablets Manufacturers and our high-quality services as a reliable Tablet Contract Manufacturer, we can provide whatever you require as a pharmaceutical company.

Fill the Number